(Q34514128)

2 August 2017

title

Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group (English)

1 reference

2 August 2017

0 references

0 references

1 reference

placebo-controlled trial

1 reference

A C Pande

1

1 reference

2 August 2017

J G Crockatt

2

1 reference

2 August 2017

C A Janney

3

1 reference

2 August 2017

J L Werth

4

1 reference

2 August 2017

G Tsaroucha

5

1 reference

2 August 2017

publication date

1 September 2000

1 reference

2 August 2017

1 reference

2 August 2017

volume

2

1 reference

2 August 2017

issue

3 Pt 2

1 reference

2 August 2017

page(s)

249-255

1 reference

Practice guideline for the treatment of patients with bipolar disorder. American Psychiatric Association

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.20305.X

7 January 2021

12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.20305.X

7 January 2021

Gabapentin in the treatment of bipolar disorder

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.20305.X

7 January 2021

Acute treatment of bipolar depression with gabapentin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.20305.X

7 January 2021

An open label study of gabapentin in the treatment of acute mania.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.20305.X

7 January 2021

Clinical experience using gabapentin adjunctively in patients with a history of mania or hypomania.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.20305.X

7 January 2021

Effect of gabapentin (Neurontin) [corrected] on mood and well-being in patients with epilepsy.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.20305.X

7 January 2021

A rating scale for mania: reliability, validity and sensitivity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.20305.X

7 January 2021

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.20305.X

7 January 2021

The assessment of anxiety states by rating

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.20305.X

7 January 2021

Independent assessment of manic and depressive symptoms by self-rating. Scale characteristics and implications for the study of mania

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.20305.X

7 January 2021

Treatment of social phobia with gabapentin: a placebo-controlled study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.20305.X

7 January 2021

10.1034/J.1399-5618.2000.20305.X

Identifiers

DOI

1 reference

2 August 2017

1 reference